Skip to Content
Upcoming Webinar

May 2026 International Monthly Webinar

Date: May 21, 2026 | 2:00 PM

 

 

Each month, NCODA’s International Monthly Webinar highlights timely topics, shared learning, and perspectives from across oncology care.

This month, we’re exploring precision oncology in veterans with non-small cell lung cancer, strategies for addressing step therapy challenges, and evolving treatment approaches for relapsed/refractory CLL/SLL.

This Month’s Lineup:

Opening remarks from Leslie Hurley, RN (New York Oncology Hematology).

Advancing Precision Oncology for Veterans with Non-Small Cell Lung CancerLaveena Meriga, DNP, AGACNP-BC, APRN, discusses the unique considerations that come with caring for veterans with non-small cell lung cancer and how precision oncology continues to shape treatment decision-making across care settings.

Pirtobrutinib in Relapsed/Refractory CLL/SLL: Expanding Options with a First-in-Class Reversible BTK Inhibitor Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC (Minnesota Oncology), breaks down the evolving role of pirtobrutinib in relapsed/refractory CLL/SLL, including key clinical trial data, efficacy and safety considerations, and guideline-based strategies for patient selection and management following prior BTKi therapy.

For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.